Humira(CF) pen 80 MG/0.8 MLS
Ended Awarded
- Contract number
- SPE2DB25FBCV2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,530
Award facts
- Contract value 100% obligated
- $32,529.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,529.80 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) pre-filled pens, 80 mg/0.8 mL formulation. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award selection. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as a primary supplier to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its DLA contracts. HUMIRA is a biologic immunosuppressant commonly used for treating rheumatoid arthritis and other autoimmune conditions in military medical settings. The delivery order reflects routine pharmaceutical supply replenishment through DLA's established prime vendor relationships, supporting the medical readiness requirements of the Department of Defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DB25FBCV2?
SPE2DB25FBCV2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FBCV2 worth?
The government has obligated $32,530 on SPE2DB25FBCV2.
Is contract SPE2DB25FBCV2 an order under another contract?
Yes. SPE2DB25FBCV2 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBCV2 competed?
The extent of competition for SPE2DB25FBCV2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award